Ain Shams University Maternity Hospital
Cairo, Egypt
Completed
NCT Number: NCT04674332
Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus
multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year–45 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 2 / Phase 3
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- pregnant women with gestational diabetes mellitus
- between 24-28 weeks gestation
Exclusion criteria
- other endocrinological abnormalities
Treatment and study plan
Long acting insulin
Druglong acting insulin analogue once daily at bed time
multiple dose regimen
Drugintermediate and short acting insulin
Primary outcomes
-
time needed to achieve glycemic control
Time frame: 1 year
glycemic control assessed by fasting and postprandial blood sugar
Sponsors and collaborators
Lead sponsor
Ain Shams University
Other
Registry information
Official study title
Comparative Study Between Use of Long Acting Insulin Versus Multiple Dose Regimen in Control of Gestational Diabetes Mellitus
Important dates
- Study start
- 2019
- Primary completion
- 2020
- Study completion
- 2020
- First posted
- Dec 19, 2020
- Registry last updated
- Sep 8, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.